Literature DB >> 15844056

Escherichia coli: development of carbapenem resistance during therapy.

Tao Hong1, Ellen Smith Moland, Baha Abdalhamid, Nancy D Hanson, Jie Wang, Cindy Sloan, Diane Fabian, Awny Farajallah, Jerome Levine, Kenneth S Thomson.   

Abstract

A 76-year-old woman had recurrent urosepsis due to extended-spectrum beta -lactamase-positive Escherichia coli. Imipenem resistance was detected after long-term imipenem-meropenem therapy. The carbapenem-hydrolyzing enzyme gene was identified as blaKPC-3. To our knowledge, this is the first documented case in which carbapenem-resistant E. coli emerged during therapy with imipenem and meropenem, and the first identification of the carbapenem-hydrolyzing enzyme in E. coli isolates.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15844056     DOI： 10.1086/429822

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  20 in total

1.  Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of enterobacteriaceae by incorporating boronic Acid.

Authors:  Fernando Pasteran; Tania Mendez; Melina Rapoport; Leonor Guerriero; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

3.  Transfer of KPC-2 Carbapenemase from Klebsiella pneumoniae to Escherichia coli in a patient: first case in Europe.

Authors:  Sara N Richter; Ilaria Frasson; Cristina Bergo; Saverio Parisi; Antonietta Cavallaro; Giorgio Palù
Journal:  J Clin Microbiol       Date:  2011-03-16       Impact factor: 5.948

4.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.

Authors:  J Kamile Rasheed; James W Biddle; Karen F Anderson; Laraine Washer; Carol Chenoweth; John Perrin; Duane W Newton; Jean B Patel
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

6.  Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008.

Authors:  Elisabeth Meyer; Frank Schwab; Barbara Schroeren-Boersch; Petra Gastmeier
Journal:  Crit Care       Date:  2010-06-14       Impact factor: 9.097

7.  Prevalence of Class D Carbapenemases among Extended-Spectrum β-Lactamases Producing Escherichia coli Isolates from Educational Hospitals in Shahrekord.

Authors:  Mohammad-Sadegh Damavandi; Abolfazl Gholipour; Mohammad Latif Pour
Journal:  J Clin Diagn Res       Date:  2016-05-01

8.  Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae.

Authors:  Fernando Pasteran; Tania Mendez; Leonor Guerriero; Melina Rapoport; Alejandra Corso
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

9.  Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.

Authors:  Jia Chang Cai; Hong Wei Zhou; Rong Zhang; Gong-Xiang Chen
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

10.  Rapid detection of blaKPC carbapenemase genes by real-time PCR.

Authors:  Musa Hindiyeh; Gill Smollen; Zehava Grossman; Daniela Ram; Yehudit Davidson; Fernando Mileguir; Marina Vax; Debbie Ben David; Ilana Tal; Galia Rahav; Ari Shamiss; Ella Mendelson; Nathan Keller
Journal:  J Clin Microbiol       Date:  2008-07-09       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.